the reference standard for diagnosing SGA, but there are conflicting reports on the best fetal growth chart or standard for classifying fetuses as growing optimally or poorly. Our group and others have previously suggested the customized approach to developing growth charts to be superior to population-based standards [1] [2] [3] as the former accounts for maternal physical and demographic characteristics. These studies were, however, retrospective with their inherent potential biases.
The INTERGROWTH-21st (IG-21) project was recently introduced with the goal of providing a universal benchmark for comparing growth across different ethnicities. 4, 5 The IG-21 project was a multicenter, multiethnic, population-based project, conducted between 2009 and 2014 in 8 countries. The project's primary aim was to study growth, health, nutrition, and neurodevelopment from < 14 weeks of gestation to 2 years of age. The IG-21 standard is in need of studies to support its external validity. Our objective was to compare the IG-21 growth standard to a customized approach for predicting pregnancies at risk for neonatal SGA and adverse neonatal outcomes.
| MATERIAL AND ME THODS
The Redefining Fetal Growth Restriction project is a prospective cohort study on women presenting for fetal growth assessment Inclusion criteria were singleton pregnancies, gestational age (GA) between 26.0 and 36.6 weeks and dating by ultrasound before 24.0 weeks. We excluded multiple gestations and fetuses with chromosomal or congenital malformations. The GA was estimated from the last menstrual period and revised by ultrasound dates when there was significant discrepancy using guidelines by Verburg et al. before 2014 and the American Congress of Obstetricians and Gynecologists afterward. 6, 7 Significant discrepancy between last menstrual period and ultrasound was defined as a difference of > 5 days up to 9 weeks of gestation, > 7 days up to 16 weeks, > 10 days up to 22 weeks, and > 14 days up to 27 weeks of gestation. centiles to any significant degree and are expected to maintain the same relative weight for GA centile. 10 The absolute percentage error, 
| Statistical analyses
Statistical analysis was performed using STATA 13 (StataCorp., College Station, TX, USA). Normal distribution of the data was judged by the Skewness and Kurtosis test. The risk ratios (RR) and 95% CI were estimated using the non-SGA group as the reference group. Sensitivity, specificity, and positive and negative predictive values for the primary and secondary outcomes using both fetal weight standards were calculated. The discriminatory ability of each growth standard was compared using area under receiver operating characteristic curves (AUC).
| Ethical approval
Institutional review board approvals were obtained at both centers (201308061 for Washington University and IRB Study #Pro00019789 for USF).
| RE SULTS
From a total of 1067 singleton pregnancies meeting our inclusion criteria over the study period (409 recruited at Washington University and 658 at the USF), customized fetal weight classification and the IG-21 standard could be performed in 1054 pregnancies. Most of the women were Caucasian of European descent (48.6%) or AfricanAmerican (30.8%). The mean BMI was 28.9 kg/m 2 ( Table 1) and mean GA at delivery was 38.5 weeks ( Table 2 ). There were significant differences in some characteristics between the women re- Table S1 ). The mean interval between EFW and birthweight was 6.7 ± 3.1 weeks. The neonatal outcomes are shown in Table 2 . SGA occurred in 139 fetuses (13.2%), and a composite adverse neonatal outcome occurred in 300 pregnancies (28.5%). We explored differences in the demographics of SGA-customized vs SGA-IG-21 groups. There were more African-American, Asian, Hispanic, and nulliparous women in the SGA-IG-21 group (Table 1) .
TA B L E 1 Cohort demographic characteristics
The SGA-customized group was on average taller, heavier, and had higher BMI compared with the SGA-IG-21 group. In addition, there were more smokers, and women with chronic hypertension or pregestational diabetes in the SGA-customized group compared with the SGA-IG group (Table 1) . The mean birthweight in the SGA-customized group was 24 g less than the SGA-IG-21 group (Table 2) and there were more preterm births in the SGA-customized only group.
Two hundred and seventy-one (25.7%) fetuses had ultrasound assessment for estimation of fetal weight between 34 and 36 weeks.
The mean absolute error between the gestational adjusted projection predicted weight and actual birthweight using IG-21 was 0.7%, TA B L E 2 Neonatal outcomes by small-for-gestational age detected by the growth standards Other groups compared with the non-SGA group using chi-squared test.
standard deviation 12.3%; and for the customized standard, the mean error was 6.5%, standard deviation 16.2%. The predicted EFW at birth below the 10th centile was -13.0% for the IG-21 and -14.0%
for the customized standards, respectively.
Due to the significant differences between the USF and Washington University cohorts, we performed a stratified analysis to evaluate whether both standards performed differently in the 2 populations. Similar to the overall analyses, the customized standard detected more cases of neonatal SGA but was not as specific as IG-21 (see Supplementary material, Table S2 ). Detection rates for neonatal outcomes were equally poor at both centers. There was a trend toward improved sensitivity of the two growth standards in the Washington University compared with the USF cohort.
| D ISCUSS I ON
This study showed that, in our population, the customized fetal growth standard identified more pregnancies at risk for SGA when compared with the IG-21 standard, but the IG-21 was more specific and if used as a posttest screening modification test, the IG-21 had a higher positive likelihood ratio and would result in a more significant alteration of risk. Moreover, both methods were poor at detecting short-term neonatal complications. These findings were similar in the cohorts recruited at both centers. These are important findings as we sought to validate these charts in our population before adopting them as our preferred standards.
Our findings are consistent with those recently reported by
Anderson et al for a New Zealand population. 11 Our study is, however, different from the former because we focused on fetal growth standards and not the neonatal birthweight standards developed by the same groups. 12, 13 The IG-21 standard was developed using multiethnic low-risk women from 8 countries with the aim of mirroring the World Health Organization Child Growth Standards and for easy generalizability to the international community. [13] [14] [15] When applied to our population, the IG-21 standard did not detect as many SGA neonates as the customized standard. Possible reasons for the lower performance of the IG-21 standard in our population may include the anthropometric characteristics, specifically the higher BMI of women in our population compared with the average participant in the IG-21 project. This is corroborated by the SGA-IG only group being shorter, of lower weight and lower BMI compared with both the non-SGA and SGA-customized only women (Table 1) . One possible explanation for the above finding is that the variable performance of the growth standards by maternal anthropometric features may be a proxy for ethnicity as demonstrated by other studies. 16, 17 The contribution of maternal weight and other anthropometric features is, however, complex; with underweight women having smaller babies, but they are also at higher risks; that women of poor socioeconomic status, often of ethnic minorities, have higher rates of SGA but also higher perinatal risks. Women with very high BMI have larger babies and also higher rates of macrosomia.
The comparison of the prediction of birthweight using the IG-21 and customized standards yielded interesting results. The mean absolute errors ranged from 0.7% to 6.5% with wide standard deviations. Our data suggest that the IG-21 standard resulted in a lower prediction error and the difference may be clinically significant.
However, the percentage predicted to be less than the 10th centile by both charts was similar.
According to previous studies, the customized standard detected more preterm SGA births; an impact likely related to the incorporation of the Hadlock's proportionality equation in the development of these standards. Alexander standard may also be considered as a limitation of our study. However, the Alexander standard has the strength of being derived from one of the largest data sets and is therefore used by several US centers for assigning birthweight centiles. Moreover, as our goal was to determine if the IG-21 prenatal EFW standards are optimal for our population, comparing them with the chart currently used by our neonatologists was critical. Furthermore, it
was not possible to calculate the fetal weight centile in 13 pregnancies due to mixed or other ethnicities, which are not available in the GROW software. Finally, because we performed the study in 2 tertiary centers and patients were referred for specific indications, our results should be considered valid only for high-risk pregnancies.
| CON CLUS ION
The customized standard detected more SGA neonates when compared with the IG-21 project standard, but it was less specific than the latter. Both standards were poor at predicting SGA neonates at risk for short-term adverse outcomes. Our findings call for validation of these standards before introducing them into clinical practice.
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